SCHEMBL215239

SCHEMBL215239

O=C1C=CC2=NN=NC2=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11195 0.67
SCHEMBL872341 0.64
SCHEMBL10609161 0.64
SCHEMBL1628355 0.59
SCHEMBL8320607 0.58
SCHEMBL49151 0.58
SCHEMBL7215917 0.57
Hydrochloric Acid SCHEMBL18422639 0.56
SCHEMBL7684904 0.55
SCHEMBL2346494 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4653437-A2 NOVEL HETEROCYCLIC COMPOUNDS Innovo Therapeutics Inc. (KR) 2025-11-26 EP claimed
WO-2024154979-A2 NOVEL HETEROCYCLIC COMPOUNDS 주식회사 이노보테라퓨틱스 2024-07-25 WO claimed
WO-2024028857-A1 PROTOPORPHYRINOGEN OXIDASE (PPO) RESISTANCE PLANT PLANTARC BIO LTD. (IL) 2024-02-08 WO claimed
WO-2023137356-A1 15-PGDH INHIBITORS VENTYX BIOSCIENCES, INC. (US) 2023-07-20 WO claimed
CN-113121526-B Method for preparing pyridotriazolone compounds by oxidation rearrangement 浙江工业大学 2022-03-18 CN claimed
CN-113135911-B Method for preparing pyridotriazolone compounds by flow chemistry 浙江工业大学 2022-03-18 CN claimed
CN-113136594-B Method for electrochemically synthesizing pyridotriazolone compounds 浙江工业大学 2022-03-15 CN claimed
CN-113136594-A Method for electrochemically synthesizing pyridotriazolone compounds 浙江工业大学 2021-07-20 CN claimed
CN-113135911-A Method for preparing pyridotriazolone compounds by flow chemistry 浙江工业大学 2021-07-20 CN claimed
CN-113121526-A Method for preparing pyridotriazolone compounds by oxidation rearrangement 浙江工业大学 2021-07-16 CN claimed
EP-2212291-A1 HETEROCYCLE PHENYL AMIDE T-TYPE CALCIUM CHANNEL ANTAGONISTS Merck Sharp & Dohme Corp. (US) 2010-08-04 EP claimed
US-20090324569-A1 BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS DECODE GENETICS EHF (IS) 2009-12-31 US claimed
US-20090136473-A1 BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS DECODE GENETICS EHF (IS) 2009-05-28 US claimed
WO-2009067600-A2 BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATION DECODE GENETICS EHF (IS) 2009-05-28 WO claimed
WO-2009067621-A1 BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS DECODE GENETICS EHF (IS) 2009-05-28 WO claimed
WO-2009054983-A1 HETEROCYCLE AMIDE T-TYPE CALCIUM CHANNEL ANTAGONISTS MERCK & CO., INC. (US) 2009-04-30 WO claimed
WO-2009054984-A1 HETEROCYCLE PHENYL AMIDE T-TYPE CALCIUM CHANNEL ANTAGONISTS MERCK & CO., INC. (US) 2009-04-30 WO claimed
US-6455469-B1 SUBSTITUTED ACETANILIDE DERIVATIVE IN COMBINATION WITH OTHER HERBICIDE TO GIVE EFFECTIVE WEED CONTORL ISHIHARA SANGYO KAISHA, LTD. (JP) 2002-09-24 US claimed
US-20020107148-A1 Herbicidal composition ISHIHARA SANGYO KAISHA, LTD. (JP) 2002-08-08 US claimed
EP-0025985-B1 2-SUBSTITUTED TRIAZOLO(4,3-1)PYRIDIN-3(2H)-ONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DEPRESSION Bristol-Myers Company (US) 1983-11-23 EP claimed